Who
Dennis Fehr
SVP, Chief Financial Officer
Company insider
Files Form 4 as: SVP, Chief Financial Officer, Cognex; SVP & Chief Financial Officer, Fluence Energy.
In numbers
- Trades disclosed
- 49
- Buys
- 1
- Sells
- 4
- Bought
- $250K
- Sold
- $2.9M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 28 Apr 2022
- Last trade
- 6 May 2026
- Last filed
- 8 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 May 2026filed 8 May 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code M | —5,394 at $0.00 | filing |
| 6 May 2026filed 8 May 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code F | $124K1,984 at $62.26 | filing |
| 6 May 2026filed 8 May 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —5,394 at $0.00 | filing |
| 6 May 2026filed 8 May 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —5,394 at $0.00 | filing |
| 6 May 2026filed 8 May 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code M | —5,394 at $0.00 | filing |
| 6 May 2026filed 8 May 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code F | $124K1,984 at $62.26 | filing |
| 18 Feb 2026filed 19 Feb 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code M | —5,085 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code F | $92K1,618 at $56.72 | filing |
| 18 Feb 2026filed 19 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —5,085 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —5,085 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code M | —5,085 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | CGNX CognexLife-science tools | SEC FORM 4 Code F | $92K1,618 at $56.72 | filing |
| 17 Feb 2026filed 19 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code A | —25,306 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code A | —25,306 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code A | —24,523 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code A | —24,523 at $0.00 | filing |
| 6 May 2025filed 7 May 2025 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code M | —3,597 at $0.00 | filing |
| 6 May 2025filed 7 May 2025 | CGNX CognexLife-science tools | SEC FORM 4 Code M | —3,597 at $0.00 | filing |
| 6 May 2025filed 7 May 2025 | CGNX CognexLife-science tools | SEC FORM 4 Code F | $29K1,056 at $27.83 | filing |
| 18 Feb 2025filed 20 Feb 2025 | CGNX Cognexoption or derivative · Life-science tools | SEC FORM 4 Code A | —68,823 at $0.00 | filing |
News
Barclays Forecasts Strong Price Appreciation for Cognex (NASDAQ:CGNX) StockCGNX · themarketsdaily.com · 12 Oct 2026Cognex (NASDAQ:CGNX) Stock Price Down 7.3% After Analyst DowngradeCGNX · themarketsdaily.com · 9 Oct 2026
0 headlines in the last 90 days name Dennis Fehr; 2 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.